HER2 imaging in the ZEPHIR study
Ann Oncol
.
2016 Apr;27(4):555-7.
doi: 10.1093/annonc/mdw033.
Epub 2016 Jan 22.
Authors
A S Clark
1
,
A DeMichele
2
,
D Mankoff
3
Affiliations
1
Department of Medicine, Division of Hematology/Oncology, Abramson Cancer Center amy.clark@uphs.upenn.edu.
2
Department of Medicine, Division of Hematology/Oncology, Abramson Cancer Center Center for Clinical Epidemiology and Biostatistics.
3
Division of Nuclear Medicine, Department of Radiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA.
PMID:
26802154
DOI:
10.1093/annonc/mdw033
No abstract available
Publication types
Editorial
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, Non-P.H.S.
Comment
MeSH terms
Diagnostic Imaging*
Humans
Receptor, ErbB-2*
Substances
Receptor, ErbB-2
Grants and funding
P30 CA016520/CA/NCI NIH HHS/United States